[Use of calcium inhibitors in neuropsychiatric pathology].
The use of calcium channel blockers is usual in cardiology today, but seem to spread to others specialties, particularly in the field of neuropsychiatry. The authors report the major clinical studies in neurology (treatment of migraines, epilepsia, dizziness and ischemic stroke) where flunarizine and nimodipine seem to have an important role. In psychiatry, their introduction is more recent. However, some encouraging results have been noted in the treatment of panic disorder, Gilles de la Tourette disease and mania.
Unité de Neuro-Psychopharmacologie, Groupe Hospitalier de la Timone, Marseille.
C
C
Lançon
M
M
Valli
G
G
Jadot
D001927:Brain Diseases / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000188:drug therapy*
D002121:Calcium Channel Blockers
Utilisation des inhibiteurs calciques en pathologie neuropsychiatrique.